Goldberg David J
Skin Laser and Surgery Specialists of New York and New Jersey, New York, NY 10022-2184, USA.
Aesthet Surg J. 2009 May-Jun;29(3 Suppl):S9-S11. doi: 10.1016/j.asj.2009.02.013.
Deformity of the tear trough region, which can occur during the aging process, can result in dark shadows under the eyes and a fatigued appearance. Augmentation of the tear trough is challenging because of the thin skin and lack of fat in the region. Adding volume to the tear trough region with a dermal filler is a nonsurgical procedure with minimal discomfort to the patient. Dermicol-P35 (Evolence; Ortho Dermatologics, Skillman, NJ) is a new, ribose crosslinked, highly purified, porcine-based collagen filler that does not require prior skin testing and has shown improved persistence compared with bovine collagen-based dermal fillers. In this article, we present the clinical outcomes of patients who have received treatment with a novel ribose crosslinked porcine collagen dermal filler for the correction of tear trough deformity.
泪沟区域的畸形可发生在衰老过程中,会导致眼周出现暗影和疲惫外观。由于该区域皮肤薄且缺乏脂肪,泪沟填充具有挑战性。使用真皮填充剂增加泪沟区域的容积是一种非手术方法,给患者带来的不适最小。Dermicol-P35(伊婉;奥伦皮肤科公司,新泽西州斯基尔曼)是一种新型的、核糖交联的、高度纯化的、猪源性胶原蛋白填充剂,无需预先进行皮肤测试,与牛胶原蛋白真皮填充剂相比,其持久性有所改善。在本文中,我们展示了接受新型核糖交联猪胶原蛋白真皮填充剂治疗以矫正泪沟畸形患者的临床结果。